Atrián-Blasco, E <br/><br/>
Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand.  [electronic resource] 

 -  Metallomics : integrated biometal science  Aug 2015 
 - 1229-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-591X 
<br/><br/><label>Standard No.: </label>10.1039/c5mt00077g  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--chemistry<br/>Copper--isolation & purification<br/>Humans<br/>Organophosphorus Compounds--pharmacology<br/>Oxidation-Reduction<br/>Reactive Oxygen Species--metabolism